Annual Total Assets
$60.54 M
+$10.18 M+20.22%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual total assets is $60.54 million, with the most recent change of +$10.18 million (+20.22%) on December 31, 2021.
- During the last 3 years, PHAS annual total assets has fallen by -$2.49 million (-3.94%).
Performance
PHAS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Assets
$22.17 M
-$16.50 M-42.67%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly total assets is $22.17 million, with the most recent change of -$16.50 million (-42.67%) on June 30, 2022.
- Over the past year, PHAS quarterly total assets has dropped by -$78.47 million (-77.97%).
Performance
PHAS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
PHAS Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.2% | -78.0% |
| 3 y3 years | -3.9% | -77.3% |
| 5 y5 years | +329.4% | - |
PHAS Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -63.4% | at low |
| 5 y | 5-year | -26.6% | -16.8% | -78.0% | at low |
| alltime | all time | -26.6% | -93.2% | -78.0% | -36.4% |
PhaseBio Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $22.17 M(-42.7%) |
| Mar 2022 | - | $38.66 M(-36.1%) |
| Dec 2021 | $60.54 M(+20.2%) | $60.54 M(-22.1%) |
| Sep 2021 | - | $77.72 M(-22.8%) |
| Jun 2021 | - | $100.64 M(-0.2%) |
| Mar 2021 | - | $100.82 M(+100.2%) |
| Dec 2020 | $50.36 M | $50.36 M(-13.5%) |
| Sep 2020 | - | $58.21 M(-17.8%) |
| Jun 2020 | - | $70.81 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $76.86 M(-6.8%) |
| Dec 2019 | $82.49 M(+30.9%) | $82.49 M(-4.3%) |
| Sep 2019 | - | $86.20 M(-11.5%) |
| Jun 2019 | - | $97.44 M(+72.8%) |
| Mar 2019 | - | $56.39 M(-10.5%) |
| Dec 2018 | $63.03 M(+347.0%) | $63.03 M(+129.3%) |
| Sep 2018 | - | $27.49 M(-7.1%) |
| Jun 2018 | - | $29.60 M(+110.0%) |
| Dec 2017 | $14.10 M(+242.5%) | $14.10 M |
| Dec 2016 | $4.12 M | - |
FAQ
- What is PhaseBio Pharmaceuticals annual total assets?
- What is the all time high annual total assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual total assets year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly total assets year-on-year change?
What is PhaseBio Pharmaceuticals annual total assets?
The current annual total assets of PHAS is $60.54 M
What is the all time high annual total assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual total assets is $82.49 M
What is PhaseBio Pharmaceuticals annual total assets year-on-year change?
Over the past year, PHAS annual total assets has changed by +$10.18 M (+20.22%)
What is PhaseBio Pharmaceuticals quarterly total assets?
The current quarterly total assets of PHAS is $22.17 M
What is the all time high quarterly total assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly total assets is $100.82 M
What is PhaseBio Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, PHAS quarterly total assets has changed by -$78.47 M (-77.97%)